Check-Cap (NASDAQ:CHEK) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK) in a report released on Tuesday morning. The firm issued a sell rating on the medical research company’s stock.

Check-Cap Price Performance

Shares of Check-Cap stock opened at $1.06 on Tuesday. The stock has a market cap of $6.20 million, a PE ratio of -0.35 and a beta of 0.17. The firm has a fifty day moving average price of $1.07 and a 200 day moving average price of $1.41. Check-Cap has a 1 year low of $0.56 and a 1 year high of $3.45.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.